Navigation Links
In Vitro Diagnostics Market is Expected to Reach USD 74.2 Billion Globally in 2018: Transparency Market Research

NEW YORK, July 31, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( "InVitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics)- Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018," market was valued at USD 46.0 billion in 2011 and is expected to reach an estimated value of USD 74.2 billion in 2018, growing at a CAGR of 7.1% from 2012 to 2018.

Browse the full report at

In vitro diagnostics (IVDs) provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. Rising number of patients suffering from infectious and chronic diseases such as sexually transmitted diseases, chronic obstructive pulmonary disease, diabetes and cancer is the most significant growth driver of this market. In addition, factors such as increasing global healthcare expenditure and demand for rapid, minimally invasive and non-invasive diagnostic tools & techniques are driving the market as well.

Related & Recently Published Reports by Transparency Market Research

In 2011, the North America IVD market held the second largest share of the global market at approximately 40%. The Asia-Pacific IVD market is expected to outperform all geographies in terms of growth rate during the forecast period. Presence of large patient pool and rising healthcare expenditure in these regions are responsible for this growth.

The clinical chemistry segment of the market held the largest market share across all major geographic regions such as the U.S., China and India in 2011. However, increase in demand for molecular diagnostics in the IVD market is expected to cut into the market share of clinical chemistry by 2018.

In 2011, Roche Diagnostics (Roche Group) held the largest share in the global in vitro diagnostics market followed by Siemens Healthcare (Siemens AG). Some of the other major companies involved in the development, manufacturing and distribution of in vitro diagnostics are Johnson & Johnson, Beckman Coulter Inc., Becton Dickinson and Company, Gen-Probe Incorporated and Thermo Fisher Scientific Corporation.

Related & Recently Published Reports by Transparency Market Research

The global in vitro diagnostics market is categorized into the following segments:

  • Market by Products


  • Market by Geography

    North America



    Rest of the World (RoW)

Browse all Medical Devices Market Research Reports@ 

Upcoming Reports in Medical Devices Market

Breast Imaging Technologies Market

Brain Monitoring Devices Market  

Diagnostic Imaging Market

Home Medical Equipment Market

PACS and RIS Market

Spine Surgery Devices Market

Disposable Syringes Market

Medical Sensors Market

Radiofrequency Ablation Device

Stem Cells Market

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Hurel Corporation Launches Cell-Based In Vitro Testing Product Suite, Milestone in Movement Away from Use of Live Animals in Drug and Toxicity Testing
2. Marken Meets Critical Demand For In Vitro Lab Shipments
3. Provitro Biosciences Awarded First-Ever U.S. Patent For Large-Scale Production Of Bamboo Plants
4. In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
5. Auxogyn And Reproductive Medicine Associates of New Jersey Partner To Advance in vitro fertilization Research
6. MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models
7. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
8. Pittsburgh Based ParentPlus Enters Collaboration with Vitrolife
9. Express Diagnostics Introducing New Products and Expanded Catalog of Drug Tests at the 2013 AACC Clinical Lab Expo
10. Molecular Diagnostics: Technologies, Markets and Companies - 2013 Report
11. QIAGEN Partners with Exosome Diagnostics to Create High-Performance Biofluid Sample Preparation Kits for Personalized Healthcare Research
Post Your Comments:
(Date:6/27/2016)... /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") ... shareholders, Clean Technology Fund I, LP and Clean Technology ... based venture capital funds which together hold approximately 59% ... diluted, as converted basis), that they have entered into ... holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... and solutions to the healthcare market. The company's primary focus is on new ... and marketing strategies that are necessary to help companies efficiently bring their products ...
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
Breaking Biology Technology:
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):